153 related articles for article (PubMed ID: 2474788)
1. Effect of praziquantel treatment on lung-stage larvae of Schistosoma mansoni in vivo.
Flisser A; McLaren DJ
Parasitology; 1989 Apr; 98 Pt 2():203-11. PubMed ID: 2474788
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of treatment of murine Schistosoma mansoni infections with praziquantel and oxamniquine correlates with infection intensity: role of host antibody.
Fallon PG; Hamilton JV; Doenhoff MJ
Parasitology; 1995 Jul; 111 ( Pt 1)():59-66. PubMed ID: 7609991
[TBL] [Abstract][Full Text] [Related]
3. Active immunization of mice with Schistosoma mansoni worm membrane antigens enhances efficacy of praziquantel.
Fallon PG; Doenhoff MJ
Parasite Immunol; 1995 May; 17(5):261-8. PubMed ID: 7675513
[TBL] [Abstract][Full Text] [Related]
4. Role of host antibody in the chemotherapeutic action of praziquantel against Schistosoma mansoni: identification of target antigens.
Brindley PJ; Strand M; Norden AP; Sher A
Mol Biochem Parasitol; 1989 May; 34(2):99-108. PubMed ID: 2496307
[TBL] [Abstract][Full Text] [Related]
5. Schistosoma mansoni: stage-dependent damage after in vivo treatment with praziquantel.
Shaw MK
Parasitology; 1990 Feb; 100 Pt 1():65-72. PubMed ID: 2107508
[TBL] [Abstract][Full Text] [Related]
6. Schistosoma mansoni and S. japonicum: decline of antibodies against diagnostic adult worm antigens (Sm31/32) following praziquantel treatment of mice.
Ruppel A; Xing Y; Dell R; Numrich P; Shi YE
Trop Med Parasitol; 1991 Dec; 42(4):325-31. PubMed ID: 1796226
[TBL] [Abstract][Full Text] [Related]
7. Anti-schistosome chemotherapy enhanced by antibodies specific for a parasite esterase.
Doenhoff MJ; Modha J; Lambertucci JR
Immunology; 1988 Dec; 65(4):507-10. PubMed ID: 3146547
[TBL] [Abstract][Full Text] [Related]
8. Increased exposure of parasite antigens at the surface of adult male Schistosoma mansoni exposed to praziquantel in vitro.
Harnett W; Kusel JR
Parasitology; 1986 Oct; 93 ( Pt 2)():401-5. PubMed ID: 2431374
[No Abstract] [Full Text] [Related]
9. Temporal differences in praziquantel- and oxamniquine-induced tegumental damage to adult Schistosoma mansoni: implications for drug-antibody synergy.
Fallon PG; Fookes RE; Wharton GA
Parasitology; 1996 Jan; 112 ( Pt 1)():47-58. PubMed ID: 8587801
[TBL] [Abstract][Full Text] [Related]
10. Immune dependence of schistosomicidal chemotherapy: an ultrastructural study of Schistosoma mansoni adult worms exposed to praziquantel and immune serum in vivo.
Modha J; Lambertucci JR; Doenhoff MJ; McLaren DJ
Parasite Immunol; 1990 May; 12(3):321-34. PubMed ID: 2117266
[TBL] [Abstract][Full Text] [Related]
11. Schistosoma mansoni: larval damage and role of effector cell(s) in the synergy between vaccine immunity and praziquantel treatment.
Piper KP; Mott RF; Hockley DJ; McLaren DJ
Parasitology; 1991 Oct; 103 Pt 2():207-24. PubMed ID: 1660590
[TBL] [Abstract][Full Text] [Related]
12. Laboratory induced resistance to praziquantel in experimental schistosomiasis.
Ismail MM; Taha SA; Farghaly AM; el-Azony AS
J Egypt Soc Parasitol; 1994 Dec; 24(3):685-95. PubMed ID: 7844435
[TBL] [Abstract][Full Text] [Related]
13. Schistosoma mansoni: enhanced efficacy of praziquantel treatment in immune mice.
Flisser A; Delgado VS; McLaren DJ
Parasite Immunol; 1989 Jul; 11(4):319-28. PubMed ID: 2506506
[TBL] [Abstract][Full Text] [Related]
14. Effect of praziquantel on the migration and survival of developmental stages of Schistosoma mansoni in mice.
Flisser A; Elsaghier AA; McLaren DJ
Int J Parasitol; 1989 Sep; 19(6):665-72. PubMed ID: 2509390
[TBL] [Abstract][Full Text] [Related]
15. Praziquantel-induced exposure of Schistosoma mansoni alkaline phosphatase: drug-antibody synergy which acts preferentially against female worms.
Fallon PG; Smith P; Nicholls T; Modha J; Doenhoff MJ
Parasite Immunol; 1994 Oct; 16(10):529-35. PubMed ID: 7870463
[TBL] [Abstract][Full Text] [Related]
16. A single dose of the antineoplastics hydroxyurea or cisplatin has praziquantel-like effects on Schistosoma mansoni worms and host mouse liver.
Eldeeb E; Fahmy S; Elbakry K; Hyder A
Biomed Pharmacother; 2018 Mar; 99():570-575. PubMed ID: 29902867
[TBL] [Abstract][Full Text] [Related]
17. Immune-dependent chemotherapy of schistosomiasis.
Fallon PG; Cooper RO; Probert AJ; Doenhoff MJ
Parasitology; 1992; 105 Suppl():S41-8. PubMed ID: 1308928
[TBL] [Abstract][Full Text] [Related]
18. Schistosoma mansoni: structural damage and tegumental repair after in vivo treatment with praziquantel.
Shaw MK; Erasmus DA
Parasitology; 1987 Apr; 94 ( Pt 2)():243-54. PubMed ID: 3108831
[TBL] [Abstract][Full Text] [Related]
19. Correlation between infection intensity, serum immunoglobulin profile, cellular immunity and the efficacy of treatment with praziquantel in murine schistosomiasis mansoni.
Nessim NG; Demerdash Z
Arzneimittelforschung; 2000 Feb; 50(2):173-7. PubMed ID: 10719623
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of hyperbaric oxygen for experimental treatment of schistosomiasis mansoni using praziquantel-free and encapsulated into liposomes: assay in adult worms and oviposition.
Frezza TF; de Souza AL; Prado CC; de Oliveira CN; Gremião MP; Giorgio S; Dolder MA; Joazeiro PP; Allegretti SM
Acta Trop; 2015 Oct; 150():182-9. PubMed ID: 26215128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
